Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Prostatic Neoplasms 5Breast Neoplasms 4Ovarian Neoplasms 3Triple Negative Breast Neoplasms 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Overweight 2Obesity 2Multiple Myeloma 2Motor Activity 2Melanoma 2Lung Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Weight Loss 1Uveal Melanoma 1Smoking Cessation 1Quality of Life 1Postoperative Complications 1Patient Compliance 1Neoplasms 1Metabolic Syndrome 1Localized Prostate Carcinoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Insulin Resistance 1Inflammation 1Hypothalamic Neoplasms 1Healthy Diet 1Glioma 1Gastrointestinal Neoplasms 1

Interventions

Interviews as Topic 3Educational Status 3Specimen Handling 2Palliative Care 2Methods 2Early Intervention, Educational 2veliparib 1spartalizumab 1siltuximab 1pamiparib 1dinaciclib 1cabozantinib 1Pharmacogenomic Variants 1Patient Comfort 1Paclitaxel 1Nutrition Assessment 1Mindfulness-Based Stress Reduction 1Mindfulness 1Magnetic Resonance Spectroscopy 1Health Promotion 1Diet Therapy 1Biopsy 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Malignant Solid Neoplasm × Diet Therapy × 1 year × Clear all
NCT06438588 2026-05-22

Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial

Mayo Clinic

Phase NA Recruiting
10 enrolled
Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡